home / stock / nktr / nktr articles
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quar...
Robert Jeffrey Ajer, Director at Nektar Therapeutics (NASDAQ:NKTR), reported a large acquisition of company stock options on September 21, accordin...
Myriam Curet, Board Member at Nektar Therapeutics (NASDAQ:NKTR), reported a large acquisition of company stock options on September 21, according t...
News, Short Squeeze, Breakout and More Instantly...
Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024 PR Newswire – NKTR-0165 Demonstrates Selective Enhancement of Treg Cell Function Through Novel Agonistic ...
Nektar Management to Present at Upcoming Investor Conferences PR Newswire SAN FRANCISCO , May 30, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences: Jefferies Healthcare C...
Nektar Therapeutics Reports First Quarter 2024 Financial Results PR Newswire SAN FRANCISCO , May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024 . Cash and ...